CIK 0001726445
- Non-accelerated filer
- Smaller reporting company
Seer, Inc.
Sign in to watch- Ticker
- SEER
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 821153150
- Phone
- +1 650-453-0000
- Business address
- 3800 BRIDGE PARKWAY, SUITE 102, REDWOOD CITY, CA, 94065
- Former names
- Seer Biosciences, Inc.
- 4 Grant or award Director acquired 9,945 shares (grant or award)
- 4 Grant or award Director acquired 9,945 shares (grant or award)
- 4 Grant or award Director acquired 9,945 shares (grant or award)
- 4 Grant or award Director acquired 9,945 shares (grant or award)
- 4 Grant or award Director acquired 5,994 shares (grant or award)
- 4 Grant or award Director acquired 9,945 shares (grant or award)
- 4 Grant or award Director acquired 5,422 shares (grant or award)
- 4 Grant or award Director acquired 9,945 shares (grant or award)
- 4 Open-market sale General Counsel and Secretary sold 8,185 shares at $8.91 ($72,923)
- 4 Open-market sale President & COO sold 4,441 shares at $8.06 ($35,794)
- 4 Open-market sale President & COO sold 52,042 shares at $10.18 ($529,933)
- 4 Grant or award Chief Commercial Officer acquired 26,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 5/A Insider Annual Insider Trading Report
- 5 Insider Annual Insider Trading Report
- 4 Grant or award General Counsel and Secretary acquired 62,000 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 62,000 shares (grant or award)
- 4 Grant or award President & COO acquired 62,000 shares (grant or award)
- 4 Grant or award CEO and Chair of the Board acquired 155,000 shares (grant or award)
Page 5 of 9 · 166 filings